Navigation Links
Hot Flushes Result of Estrogen Addiction
Date:3/26/2010

UBC Professor of Endocrinology Dr. Jerilynn C. Prior presents finding on estrogen addition and its treatment with progesterone at Women's Health Congress 2010 in Washington DC

Vancouver, Canada (PRWEB) March 26, 2010 -- A woman having a hot flush would fail a lie detector test. She may also be addicted to estrogen, according to Dr. Jerilynn C. Prior, author and Professor of Endocrinology at the University of British Columbia. Prior will be presenting on the idea of 'estrogen addiction' and its treatment with progesterone at the Women's Health Congress, 2010 in Washington, DC, held March 26 to 28 at the Crystal Gateway Marriott.

The positive lie detector test isn't because she's not telling the truth, but because "she's experiencing a massive release of brain chemicals that increases skin blood flow and changes her skin chemistry to produce a galvanic response, or positive lie detector test," explains Prior. "Integrating what we know about hot flushes has led to the hypothesis that the brain exposed to prolonged high estrogen levels reacts like the brain of an addict without a fix when estrogen levels drop. The best animal model of hot flushes is the heroin-addicted mouse."

The estrogen addiction idea fits with the reality that most estrogen-treated women who take it for hot flushes will experience an increased number and intensity of hot flushes and night sweats when they stop estrogen. Prior has found that progesterone helps women to gradually decrease and stop estrogen without a rebound increase in hot flushes (www.cemcor.ubc.ca "Stopping Estrogen").

"The importance of the estrogen addiction idea is that it explains how progestins or progesterone work to effectively treat hot flushes," says Prior. Estrogen and progesterone work together in every tissue of women's bodies she writes in the book she co-authored with Susan Baxter, The Estrogen Errors--Why Progesterone is Better for Women's Health.

A study in Neuropsychopharmacology (2004) shows that women are at greater risk for cocaine addiction than are men. "Estrogens increase the excitability of the brain and thus the risk for dependence or addiction. Progesterone, on the other hand, calms the brain and decreases anxiety," says Prior. Extensive animal research and some early human studies show that progesterone decreases drug craving and lessens the psychological and physiological effects of cocaine's "high."

Jerilynn C. Prior, MD, FRCPC, ABIM, ABEM, is a Professor of Medicine, Endocrinology at the University of British Columbia (Vancouver, Canada). She is the founder and Scientific Director of the Centre for Menstrual Cycle and Ovulation Research (CeMCOR http://www.cemcor.ubc.ca/) and has published over 120 peer-reviewed scientific articles in medical journals including The New England Journal of Medicine and Lancet. Prior is invited as a Visiting Lecturer at institutions across Canada and the US (including the New York Academy of Sciences and Harvard School of Public Health) as well as internationally. She is author of the award-finalist book, Estrogen's Storm Season--Stories of Perimenopause (CeMCOR, 2005, [reprinted 2007 Vancouver, Canada), and The Estrogen Errors--Why Progesterone is Better for Women's Health.

For more information or to interview Dr Prior, please contact Lori Smithers: lori(dot)smithers(at)vch(dot)ca (Dr Prior's assistant) 604-875-5927 or the Conference Media Center at 703-271-5181.

# # #

Read the full story at http://www.prweb.com/releases/2010/03/prweb3794464.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Guaranteed PR Results from Borough PR with the New ‘PRcheck'
2. Abbreviated Trials Yield Misleading Results: Study
3. Residency match results not encouraging for adults needing primary care
4. Dear Doctor Magazine Reveals Makeover Contest Winner's Results and Expands Contest to Include Additional Winners
5. MDS Reports First Quarter Fiscal 2010 Financial Results
6. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results
7. Late-stage melanoma results in economic burden
8. Patheon reports first quarter fiscal 2010 results
9. Omeros Corporation to Host Conference Call on Fourth Quarter and Full Year 2009 Results on March 31
10. Healthcare Trust of America, Inc. Announces Fourth Quarter and Year-End 2009 Financial Results
11. MedQuist Reports Results for the Fourth Quarter and 2009
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hot Flushes Result of Estrogen Addiction 
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
Breaking Medicine Technology: